Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Aumentando a cobertura do tratamento da desnutrição aguda grave (SAM) na Etiópia (R-SWITCH)

9 de novembro de 2026 atualizado por: International Food Policy Research Institute

Efeito do aproveitamento de estruturas a nível comunitário para reforçar a prevenção, rastreio e tratamento da desnutrição aguda grave na Etiópia

The R-SWITCH intervention aims to address the low coverage of treatment for severe wasting (SAM) by leveraging existing community groups to deliver an integrated package focused on prevention, screening, referral, and treatment of SAM. It includes behavior change communication on child nutrition and health, active screening, improved passive screening at health posts, and follow-up of referred cases and those enrolled in outpatient treatment programs (OTP). The primary objectives of the R-SWITCH studies are to assess the intervention's impact on OTP coverage, identify implementation barriers and facilitators, and evaluate its cost-efficiency and cost-effectiveness.

Visão geral do estudo

Descrição detalhada

Despite the high mortality risk of severe wasting (also referred to as severe acute malnutrition or SAM), only a small proportion of children with severe wasting are currently identified and admitted to available outpatient treatment programs (OTP). In 2020, an estimated 4.9 million children with severe wasting received treatment, approximately a third of the total burden. Outside of humanitarian settings, this proportion is even lower (estimated to be around 15%). These figures highlight the urgent need to increase treatment coverage to meet the Sustainable Development Goals (SDG), which aim to reduce the prevalence of child wasting to less than 5% by 2025 and less than 3% by 2030. The continuum of care for SAM, from case identification, referral to treatment, and post-treatment follow-up, is hampered by several barriers including caregiver lack of awareness on the risks and treatment services of SAM, stigma related to SAM, poor accessibility to treatment, frequent stockouts of treatment inputs, and the overall workload faced by first-line health workers.

The R-SWITCH intervention will leverage existing community groups to deliver an integrated package aimed at preventing SAM through behavior change communication (BCC) on child nutrition and health, increasing wasting screening coverage through active screening, family-led MUAC and improved passive screening health posts, increasing treatment coverage through follow-up of earlier referred cases, cases enrolled in OTP, and children who completed OTP and recovered.

The primary objectives of the R-SWITCH studies are:

  • To assess the impact of the R-SWITCH intervention on SAM OTP coverage
  • To identify implementation barriers and facilitators
  • To assess the cost-efficiency and cost-effectiveness of the intervention package and services

Tipo de estudo

Intervencional

Inscrição (Estimado)

1080

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

      • Jimma, Etiópia
        • Recrutamento
        • Kersa and Jeldessa woredas
        • Investigador principal:
          • Lieven Huybregts, PhD
        • Investigador principal:
          • Tefera Belachew, PhD

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

6 meses a 5 anos (Filho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Child 6-59 months of age
  • Suffering from SAM (defined as MUAC < 115mm or presence of bilateral pitting edema or Weight-for-Length Z-score <-3) OR currently enrolled in SAM OTP

Exclusion Criteria:

- Anthropometric malformation or being handicapped which hampers anthropometric measurements.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Pesquisa de serviços de saúde
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Sem intervenção: Standard of Care
  • Usual screening of wasting by health extension workers (HEW) using MUAC
  • Previous introduction of Family-led MUAC (not maintained)
  • Behavior Change Communication (BCC) offered by Health extension worker (low intensity)
  • Treatment of SAM at health post or health center
  • Follow-up of SAM OTP defaults through home visits by HEW (very low intensity)
Experimental: R-SWITCH integrated intervention package
  1. Monthly group meetings of AFD community groups
  2. Introduction of weight-for-age Z-score <-3 as an additional screening criterion
  3. Promotion of Family-led MUAC screening and SAM awareness to fathers, community and religious leaders
  4. Follow-up and counselling during home visits by AFD leaders
  5. Strengthening communication between HEW and AFDs
  1. Monthly group meetings of Alliance for Development (AFD) community groups) and their members (caregivers of children 0-59 months of age):

    • Introduction and refresher of Family-led MUAC
    • Active screening of wasting by AFD
    • Group SBCC on Infant and Young Child Feeding (IYCF), health and Water, Sanitation and Hygiene (WaSH) with a focus on SAM
    • Promotion of health services such as GMP
  2. Introduction of weight-for-age Z-score <-3 as screening criterion for passive screening by health extension workers at any contact with children (e.g. during GMP)

  3. Promotion of Family-led MUAC screening and SAM awareness to fathers during male agricultural/pastoralist extension activities and by community and religious leaders (creating social support)

  4. Follow-up and counselling during home visits by AFD leaders of i) earlier referred cases of SAM, ii) cases enrolled in SAM OTP, iii) and recovered SAM cases discharged from OTP

  5. Strengthening communication between HEW and AFDs

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Period prevalence of SAM OTP treatment coverage in children 6-59 months of age
Prazo: After 24 months of program implementation

Defined as the proportion of children with Severe Acute Malnutrition (SAM) or enrolled in the SAM Outpatient Therapeutic program (OTP) that are "under treatment".

  • SAM is defined as a Mid-Upper Arm Circumference <115mm or a weight-for-height Z-score <-3 (relative to the World Health Organization (WHO) 2006 growth standards) or presence of bilateral pitting edema.

  • "Under treatment" is defined as:

    • the caregiver acknowledging the child is enrolled in a SAM OTP AND
    • the child was fed ready-to-use therapeutic food (RUTF) over the last three days AND
    • the caregiver can either show at least one full RUTF sachet OR more than one empty RUTF sachet.
After 24 months of program implementation

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Point prevalence of SAM OTP treatment coverage in children 6-59 months of age
Prazo: After 24 months of program implementation

Defined as the proportion of children with SAM at the time of the survey that are under treatment (see definition under primary outcome

After 24 months of program implementation
Period prevalence of SAM OTP treatment coverage in the subgroup of treatment eligible children 6-59 months of age
Prazo: After 24 months of program implementation

Defined as the proportion of children with Severe Acute Malnutrition (SAM) or Severe underweight (weight-for-age Z-score <-3) or enrolled in the SAM Outpatient Therapeutic program (OTP) that are "under treatment".

  • SAM is defined as a Mid-Upper Arm Circumference <115mm or a weight-for-height Z-score <-3 (relative to the WHO 2006 growth standards) or presence of bilateral pitting edema.

  • "Under treatment" is defined as:

    • the caregiver acknowledging the child is enrolled in a SAM OTP AND
    • the child was fed ready-to-use therapeutic food (RUTF) over the last three days AND
    • the caregiver can either show at least one full RUTF sachet OR more than one empty RUTF sachet.
After 24 months of program implementation
Screening coverage of SAM
Prazo: After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with SAM screened for wasting over the last 30 days (as reported by the caregiver)

After 24 months of program implementation
Screening coverage of severe underweight
Prazo: After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with severe underweight (weight-for-age Z-score <-3 relative to WHO 2006 growth standard) screened over the last 30 days (as reported by the caregiver)

After 24 months of program implementation
Platform specific screening coverage of SAM
Prazo: After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with SAM screened for wasting over the last 30 days (as reported by the caregiver):

  • by Family-led MUAC ( screening by family members using a MUAC tape)
  • during growth monitor promotion (GMP) consultations
  • during Integrated management of childhood illness consultations
After 24 months of program implementation
Growth Monitoring Promotion (GMP) consultation attendance
Prazo: After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with SAM that attended GMP over the last 30 days (as reported by the caregiver).

After 24 months of program implementation
AFD group meeting attendance
Prazo: After 24 months of program implementation

Defined as the proportion of of children aged 6-59 months with SAM that attended the monthly AFD group contact over the last 30 days (as reported by the caregiver).

After 24 months of program implementation
AFD home visit coverage
Prazo: After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with SAM and children enrolled in SAM OTP that received a home visit by an AFD leader/member over the last 30 days (as reported by the caregiver).

After 24 months of program implementation
Prevalence of SAM
Prazo: After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with SAM (defined as WHZ <-3 or a MUAC < 115 mm or the presence of bilateral pitting edema). To calculate WHZ scores the 2006 WHO growth reference will be used

After 24 months of program implementation
Prevalence of wasting
Prazo: After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with wasting (defined as WHZ <-2 or a MUAC < 125 mm or the presence of bilateral pitting edema). To calculate WHZ scores the 2006 WHO growth reference will be used

After 24 months of program implementation
Prevalence of stunting
Prazo: After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with stunting (defined as height-for-age Z-scores (HAZ) <-2 or a MUAC < 125 mm or the presence of bilateral pitting edema). To calculate HAZ scores the 2006 WHO growth reference will be used

After 24 months of program implementation
Prevalence of underweight and severe underweight
Prazo: After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with underweight (defined as weight-for-age Z-scores (WAZ) <-2 ) and severe underweight (defined as WAZ <-3 ). To calculate WAZ scores the 2006 WHO growth reference will be used

After 24 months of program implementation
Mean height-for-age Z-score (HAZ)
Prazo: After 24 months of program implementation

In 6-59 months old children. To calculate HAZ scores the 2006 WHO growth reference will be used

After 24 months of program implementation
Mean weight-for-height Z-score (WHZ)
Prazo: After 24 months of program implementation

In 6-59 months old children.To calculate WHZ scores the 2006 WHO growth reference will be used

After 24 months of program implementation
Mean weight-for-age Z-score (WAZ)
Prazo: After 24 months of program implementation

In 6-59 months old children.To calculate WAZ scores the 2006 WHO growth reference will be used

After 24 months of program implementation
Mean mid-upper arm circumference (MUAC)
Prazo: After 24 months of program implementation

In 6-59 months old children.

After 24 months of program implementation
Caregiver's knowledge related to breastfeeding, complementary feeding,child health and hygiene, the condition of severe acute malnutrition, outpatient therapeutic programs, screening of wasting
Prazo: After 24 months of program implementation

Presented as a total standardized score and by knowledge domain

After 24 months of program implementation
Vaccination coverage
Prazo: After 24 months of program implementation

Proportion of children aged 6-18 months with SAM or enrolled in SAM OTP who received all age-recommended immunizations

After 24 months of program implementation
Introduction of (semi) solid and soft complementary foods
Prazo: After 24 months of program implementation

The proportion of children 6-8 months of age who consumed (semi) solid and soft complementary foods during the previous day

After 24 months of program implementation
Minimum dietary diversity in infants and young children (6-23 mo)
Prazo: After 24 months of program implementation

The proportion of study children aged 6-23 months who consumed at least 5 of the 8 food groups (including breast milk) during the previous day

After 24 months of program implementation
Nr of food groups consumed by infants and young children (6-59 mo)
Prazo: After 24 months of program implementation

The mean number of food groups consumed during the previous day by study children aged 6-59

After 24 months of program implementation
Minimum meal frequency in infants and young children
Prazo: After 24 months of program implementation

Defined as the proportion of study children who had eaten during the previous day: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 monthsMinimum meal frequency for children, defined as the proportion of children who had eaten the day before the survey: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 months.

After 24 months of program implementation
Minimum acceptable diet in infants and young children
Prazo: After 24 months of program implementation

Defined as the proportion of study children aged 6-23 months with both minimal dietary diversity and minimal meal frequency during the previous day

After 24 months of program implementation
Continuous breastfeeding 12-23 months
Prazo: After 24 months of program implementation

Defined as the proportion of children aged 12-23 months breastfed during the previous day

After 24 months of program implementation
Egg and/or flesh food consumption
Prazo: After 24 months of program implementation

Proportion of children 6-23 months of age who consumed egg and/or flesh food during the previous day

After 24 months of program implementation
Sweet beverage consumption
Prazo: After 24 months of program implementation

Proportion of children 6-23 months of age who consumed a sweet beverage during the previous day

After 24 months of program implementation
Zero vegetable or fruit consumption consumption
Prazo: After 24 months of program implementation

Proportion of children 6-23 months of age who did not consume any vegetables or fruits during the previous day

After 24 months of program implementation
Minimum milk feeding frequency for non-breastfed children
Prazo: After 24 months of program implementation

Proportion of non-breastfed children 6-23 months of age who consumed at least two milk feeds during the previous day

After 24 months of program implementation
Weight-for-length Z-score and MUAC at Severe Acute Malnutrition (SAM) Outpatient Therapeutic Feeding program (OTP)
Prazo: 24 months from baseline until endline of the study

Weight-for-length Z-score (relative to the 2006 WHO reference) and MUAC(mm)

24 months from baseline until endline of the study
SAM OTP adherence
Prazo: 24 months from baseline until endline of the study

Defined as the proportion of cases enrolled to SAM OTP who received timely treatment from dedicated services (health center or health post) until anthropometric recovery

24 months from baseline until endline of the study
Weight gain rate during SAM OTP
Prazo: 24 months from baseline until endline of the study

Defined as the weight gain during SAM OTP divided by the length of treatment and divided by the child's weight

24 months from baseline until endline of the study
SAM OTP outcomes (drop-out, death, transfer, non-response rates)
Prazo: 24 months from baseline until endline of the study

Among cases admitted to SAM OTP

24 months from baseline until endline of the study
SAM OTP duration
Prazo: 24 months from baseline until endline of the study

Defined as the number of days spent in SAM OTP (from admission to discharge)

24 months from baseline until endline of the study

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Lieven Huybregts, PhD, International Food Policy Research Institute
  • Investigador principal: Tefera Belachew, PhD, Ethiopian Public Health Association

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

2 de maio de 2024

Conclusão Primária (Real)

30 de setembro de 2026

Conclusão do estudo (Estimado)

30 de junho de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

18 de abril de 2024

Enviado pela primeira vez que atendeu aos critérios de CQ

23 de abril de 2024

Primeira postagem (Real)

24 de abril de 2024

Atualizações de registro de estudo

Última Atualização Postada (Real)

12 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

9 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever